Anaphylaxis Treatment Market to Grow at a CAGR of 8.7% to reach US$ 4,787.66 million from 2021 to 2028
The anaphylaxis treatment market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% during 2021–2028.
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. As per the Asthma and Allergy Foundation of America (AAFA), in the US, every year, there are around 200,000 hospital visits due to food allergies. The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. However, poor accessibility to epinephrine auto-injectors in low-income countries hinders the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anaphylaxis Treatment Market: Strategic Insights
Market Size Value in US$ 2,664.66 Million in 2021 Market Size Value by US$ 4,787.66 Million by 2028 Growth rate CAGR of 8.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anaphylaxis Treatment Market: Strategic Insights
| Market Size Value in | US$ 2,664.66 Million in 2021 |
| Market Size Value by | US$ 4,787.66 Million by 2028 |
| Growth rate | CAGR of 8.7% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Incidence of Anaphylaxis
Anaphylaxis is a severe, life‑threatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a non-self by a human body. Typical indications of this condition include swallowing and breathing difficulties, skin redness and itching, accelerated heart rate, wheezing, rapid breathing rate, and lowering blood pressure. The incidence of anaphylaxis is increasing around the world. According to the National Institute for Health and Care Excellence (NICE), anaphylaxis causes more than 20 deaths every year in the UK. As per the European Academy of Allergy and Clinical Immunology data, ~150 million Europeans suffer from chronic allergic diseases every year. Therefore, the rising incidence of allergies is leading to surge in anaphylaxis cases. Moreover, as per the Allergy Facts by the American College of Allergy, Asthma & Immunology, more than 50 million people experience different types of allergies every year.
1–15% of the US population is at the risk of having an anaphylactic reaction when exposed to one or more allergens, and up to 1% of these patients die due to anaphylaxis. The condition results in ~1,500 deaths per year in the US; also list allergies as the sixth-leading circumstance of chronic illness. Moreover, as per the Asthma and Allergy Foundation of America (AAFA), due to increasing food allergic reactions, the number of hospital visits has increased. Food allergies are the cause of more than 200,000 emergency room (ER) visits annually. Food Allergy Research & Education states that more than 32 million Americans live with life-threatening food allergies. Due to the growing prevalence of allergies, the economic burden on healthcare systems in many countries is increasing. For instance, according to Allergy Facts, the annual cost of managing the cases of allergies is more than US$ 18 billion in the US. Thus, the burgeoning incidence of anaphylaxis is driving the growth of the market.
Medication Type -Based Insights
Based on medication type, the anaphylaxis treatment market is segmented into epinephrine, antihistamines, steroids, beta-agonist, and others. The epinephrine segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
Route of Administration -Based Insights
Based on route of administration, the anaphylaxis treatment market is segmented into oral, parenteral, and others. The parenteral segment held the largest share of the market in 2020, whereas the oral segment is anticipated to register the highest CAGR of 8.9% in the market during the forecast period.
Allergy Type-based Insights
Based on allergy type, the anaphylaxis treatment market is segmented into food allergy, medications, insect stings, and others. The food allergy segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.
Distribution Channel-based Insights
Based on distribution channel, the anaphylaxis treatment market is segmented into hospital pharmacies, retail sales, drug store mail, and others. The retail sales segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the anaphylaxis treatment market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Anaphylaxis Treatment Market Report Scope
Anaphylaxis Treatment Market – by Medication Type
- Epinephrine
- Antihistamines
- Steroids
- Beta-Agonist
- Others
Anaphylaxis Treatment Market – by Route of Administration
- Oral
- Parenteral
- Others
Anaphylaxis Treatment Market – by Allergy Type
- Food Allergy
- Medications
- Insect Stings
- Others
Anaphylaxis Treatment Market – by Distribution Channel
- Hospital Pharmacies
- Retail Sales
- Others
Anaphylaxis Treatment Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Medication Type , Route of Administration , Allergy Type , and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.
The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anaphylaxis Treatment Market – By Medication Type
1.3.2 Global Anaphylaxis Treatment Market – By Application
1.3.3 Global Anaphylaxis Treatment Market – By Allergy Type
1.3.4 Global Anaphylaxis Treatment Market – By End User
1.3.5 Global Anaphylaxis Treatment Market – By Geography
2. Anaphylaxis Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Anaphylaxis Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market – Global Analysis
6.1 Global Anaphylaxis Treatment Market Revenue Forecast and Analysis
6.2 Global Anaphylaxis Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Anaphylaxis Treatment Market Analysis – By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis – By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Anaphylaxis Treatment Market Analysis – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10. Anaphylaxis Treatment Market Analysis and Forecast – By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Global Anaphylaxis Treatment Market – Geographical Analysis
11.1 North America: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 North America: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.4 North America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.5 North America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.6 North America: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.7 North America: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.8 North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.8.1 US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.1.1 US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.1.2 US: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.8.1.3 US: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.8.1.4 US: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.8.1.5 US: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.8.1.6 US: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.8.2 Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.2.1 Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.2.2 Canada: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.8.2.3 Canada: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.8.2.4 Canada: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.8.2.5 Canada: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.8.2.6 Canada: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.8.3 Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.3.1 Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.8.3.2 Mexico: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.8.3.3 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.8.3.4 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.8.3.5 Mexico: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.8.3.6 Mexico: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.2 Europe: Anaphylaxis Treatment Market
11.2.1 Overview
11.2.2 Europe: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Anaphylaxis Treatment Market, by Device, 2019–2028 (USD Million)
11.2.4 Europe: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.5 Europe: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.6 Europe: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.2.7 Europe: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.2.8 Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.2.8.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.1.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.1.2 Germany: Anaphylaxis Treatment Market, by Medication Type 2019–2028 (USD Million)
11.2.8.1.3 Germany: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.1.4 Germany: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.1.5 Germany: anaphylaxis treatment Market, by Allergy Type 2019–2028 (USD Million)
11.2.8.1.6 Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.2.8.2 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.2.1 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.2.2 UK: Anaphylaxis Treatment Market, Medication Type, 2019–2028 (USD Million)
11.2.8.2.3 UK: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.2.4 UK: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.2.5 UK: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.2.8.2.6 UK: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.2.8.3 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.3.1 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.3.2 France: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.2.8.3.3 France: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.3.4 France: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.2.8.3.5 France: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.2.8.3.6 France: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.2.8.4 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.4.1 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.4.2 Italy: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.2.8.4.3 Italy: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.4.4 Italy: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.4.5 Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.2.8.4.6 Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.2.8.5 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.5.1 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.5.2 Spain: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.2.8.5.3 Spain: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.5.4 Spain: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.5.5 Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.2.8.5.6 Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.2.8.6 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.6.1 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.2.8.6.2 Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.2.8.6.3 Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.6.4 Rest of Europe: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.2.8.6.5 Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.2.8.6.6 Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3 Asia Pacific: Anaphylaxis Treatment Market
11.3.1 Overview
11.3.2 Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.4 Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.5 Asia Pacific: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.6 Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.7 Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8 Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.3.8.1 Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.1.1 Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.1.2 Japan: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.1.3 Japan: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.1.4 Japan: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.1.5 Japan: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.1.6 Japan: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8.2 China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.2.1 China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.2.2 China: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.2.3 China: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.2.4 China: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.2.5 China: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.2.6 China: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8.3 India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.3.1 India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.3.2 India: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.3.3 India: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.3.4 India: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.3.5 India: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.3.6 India: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8.4 South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.4.1 South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.4.2 South Korea: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.4.3 South Korea: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.4.4 South Korea: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.4.5 South Korea: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.4.6 South Korea: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8.5 Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.5.1 Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.5.2 Australia: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.5.3 Australia: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.5.4 Australia: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.5.5 Australia: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.5.6 Australia: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.3.8.6 Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.6.1 Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.3.8.6.2 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.3.8.6.3 Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.6.4 Rest of Asia Pacific: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.3.8.6.5 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.3.8.6.6 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.4 Middle East & Africa: Anaphylaxis Treatment Market
11.4.1 Overview
11.4.2 Middle East & Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.4.4 Middle East & Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.5 Middle East & Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.6 Middle East & Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.4.7 Middle East & Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.8 Middle East and Africa: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.4.8.1 Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.1.1 Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.1.2 Saudi Arabia: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.4.8.1.3 Saudi Arabia: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.1.4 Saudi Arabia: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.1.5 Saudi Arabia: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.4.8.1.6 Saudi Arabia: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.8.2 UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.2.1 UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.2.2 UAE: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.4.8.2.3 UAE: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.2.4 UAE: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.2.5 UAE: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.4.8.2.6 UAE: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.8.3 South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.3.1 South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.3.2 South Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.4.8.3.3 South Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.3.4 South Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.3.5 South Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.4.8.3.6 South Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.8.4 Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.4.1 Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.4.8.4.2 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.4.8.4.3 Rest of Middle East and Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.4.4 Rest of Middle East and Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.4.8.4.5 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.4.8.4.6 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.5 South and Central America: Anaphylaxis Treatment Market
11.5.1 Overview
11.5.2 South and Central America: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.4 South and Central America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.5 South and Central America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.6 South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)
11.5.7 South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)
11.5.8 South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)
11.5.8.1 Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.1.1 Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.1.2 Brazil: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.1.3 Brazil: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.1.4 Brazil: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.1.5 Brazil: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.5.8.1.6 Brazil: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.5.8.2 Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.2.1 Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.2.2 Argentina: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.2.3 Argentina: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.2.4 Argentina: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.2.5 Argentina: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)
11.5.8.2.6 Argentina: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)
11.5.8.3 Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.3.1 Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.3.2 Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.3.3 Rest of South and Central America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.3.4 Rest of South and Central America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.5.8.3.5 Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2018-2027 (USD Million)
11.5.8.3.6 Rest of South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
12. Impact Of COVID-19 Pandemic on Global Anaphylaxis Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Anaphylaxis Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Adamis Pharmaceuticals Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ALK-Abelló A/S
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Amneal Pharmaceuticals, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIOPROJET
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 GlaxoSmithKline plc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Merck & Co., Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MYLAN N.V.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Pfizer Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms, Anaphylaxis Treatment Market
LIST OF TABLES
Table 1. North America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Epinephrine Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Others Treatment Market Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 7. US: Epinephrine Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Others Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. US: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. US Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Europe: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Europe: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. Germany: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 27. Germany: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 28. Germany: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Germany: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 31. UK: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 32. UK: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 33. UK: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 34. UK: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 35. UK: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 36. France: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 37. France: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 38. France: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 39. France: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 40. France Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 41. Italy: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 42. Italy: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 43. Italy: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 44. Italy: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 45. Italy: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 46. Spain: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 47. Spain: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 48. Spain: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 49. Spain: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 50. Spain: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific: Anaphylaxis Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific: Others Treatment Market Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 61. Japan: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 62. Japan: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 63. Japan: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 64. Japan: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 65. Japan: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 66. China: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 67. China: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 68. China: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 69. China: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 70. China: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 71. India: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 72. India: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 73. India: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 74. India: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 75. India: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 82. Australia: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 83. Australia: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 84. Australia: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 102. UAE: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 103. UAE: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 104. UAE: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 136. Organic Developments Done by Companies
Table 137. Inorganic Developments Done by Companies
Table 138. List of Abbreviation
LIST OF FIGURES
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. Anaphylaxis Treatment Market Segmentation, By Region
Figure 3. Anaphylaxis Treatment Market Overview
Figure 4. Epinephrine Segment Held Largest Share of Anaphylaxis Treatment Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Anaphylaxis Treatment Market, by Geography (US$ Million)
Figure 7. Global Anaphylaxis Treatment Market – Leading Country Markets (US$ Million)
Figure 8. Global Anaphylaxis Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Anaphylaxis Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 15. Global Anaphylaxis Treatment Market – By Geography Forecast and Analysis – 2020- 2028
Figure 16. Market Positioning of Key Players in Global Anaphylaxis Treatment Market
Figure 17. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 18. Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 24. Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 28. Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 33. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 35. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 36. North America: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 37. North America Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 38. North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 39. US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 43. Europe Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 44. Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 45. Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Asia Pacific: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 52. Asia Pacific: Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 54. Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Middle East & Africa: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 61. Middle East & Africa: Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 62. Middle East and Africa: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 63. Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. South and Central America: Anaphylaxis Treatment Market, By Key Country – Revenue (2020) (USD Million)
Figure 68. South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)
Figure 69. South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)
Figure 70. Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)
Figure 71. Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)
Figure 72. Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic in European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia-Pacific Countries Markets
Figure 76. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 77. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 78. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Anaphylaxis Treatment Market
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For